PULSE BIOSCIENCES, INC.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
PLSE$58.17+9.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except par value)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $118,038 | $44,365 |
| Prepaid expenses and other current assets | 1,411 | 963 |
| Total current assets | 119,449 | 45,328 |
| Property and equipment, net | 1,160 | 1,528 |
| Intangible assets, net | 1,220 | 1,886 |
| Goodwill | 2,791 | 2,791 |
| Right-of-use assets | 7,163 | 7,256 |
| Other assets | 677 | 365 |
| Total assets | $132,460 | $59,154 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $1,673 | $1,836 |
| Accrued expenses | 7,027 | 3,814 |
| Lease liability, current | 1,355 | 1,058 |
| Total current liabilities | 10,055 | 6,708 |
| Lease liability, less current portion | 7,543 | 8,086 |
| Total liabilities | 17,598 | 14,794 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; authorized – 50,000 shares; no shares issued and outstanding | — | — |
| Common stock, $0.001 par value; authorized – 500,000 shares; issued and outstanding – 65,926 shares and 55,144 shares at December 31, 2024 and 2023, respectively | 66 | 55 |
| Additional paid-in capital | 505,296 | 381,220 |
| Accumulated other comprehensive income (loss) | — | — |
| Accumulated deficit | (390,500) | (336,915) |
| Total stockholders’ equity | 114,862 | 44,360 |
| Total liabilities and stockholders’ equity | $132,460 | $59,154 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.